Strides Continues to Deliver Exceptional Performance With Highest Ever Quarterly EBITDA in Q3FY26
Bangalore, India, Jan 30: Strides Pharma Science Ltd today announced its consolidated financial results for the quarter (Q3 FY26) and nine months (9MFY26) ended December 31, 2025, reflecting strong growth…